Patient-reported outcomes from a randomized phase II study of the deferasirox film-coated tablet in patients with transfusion-dependent anemias

BACKGROUND: Adherence to long-term chelation therapy in transfusion-dependent patients is critical to prevent iron overload-related complications. Once-daily deferasirox dispersible tablets (DT) have proven long-term efficacy and safety in patients ≥2 years old with chronic transfusional iron overlo...

Descripción completa

Detalles Bibliográficos
Autores principales: Taher, Ali T., Origa, Raffaella, Perrotta, Silverio, Kouraklis, Alexandra, Ruffo, Giovan Battista, Kattamis, Antonis, Goh, Ai-Sim, Huang, Vicky, Zia, Aiesha, Herranz, Raquel Merino, Porter, John B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245526/
https://www.ncbi.nlm.nih.gov/pubmed/30453981
http://dx.doi.org/10.1186/s12955-018-1041-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245526/
https://www.ncbi.nlm.nih.gov/pubmed/30453981
http://dx.doi.org/10.1186/s12955-018-1041-5

Ejemplares similares